↓ Skip to main content

Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines

Overview of attention for article published in Journal of Medical Toxicology, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#23 of 732)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
4 news outlets
blogs
4 blogs
policy
2 policy sources
twitter
9 X users
facebook
1 Facebook page
wikipedia
5 Wikipedia pages
linkedin
1 LinkedIn user

Citations

dimensions_citation
299 Dimensions

Readers on

mendeley
379 Mendeley
citeulike
1 CiteULike
Title
Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines
Published in
Journal of Medical Toxicology, January 2012
DOI 10.1007/s13181-011-0202-2
Pubmed ID
Authors

Christopher D. Rosenbaum, Stephanie P. Carreiro, Kavita M. Babu

Abstract

Despite their widespread Internet availability and use, many of the new drugs of abuse remain unfamiliar to health care providers. The herbal marijuana alternatives, like K2 or Spice, are a group of herbal blends that contain a mixture of plant matter in addition to chemical grade synthetic cannabinoids. The synthetic cathinones, commonly called "bath salts," have resulted in nationwide emergency department visits for severe agitation, sympathomimetic toxicity, and death. Kratom, a plant product derived from Mitragyna speciosa Korth, has opioid-like effects, and has been used for the treatment of chronic pain and amelioration of opioid-withdrawal symptoms. Salvia divinorum is a hallucinogen with unique pharmacology that has therapeutic potential but has been banned in many states due to concerns regarding its psychiatric effects. Methoxetamine has recently become available via the Internet and is marked as "legal ketamine." Moreover, the piperazine derivatives, a class of amphetamine-like compounds that includes BZP and TMFPP, are making a resurgence as "legal Ecstasy." These psychoactives are available via the Internet, frequently legal, and often perceived as safe by the public. Unfortunately, these drugs often have adverse effects, which range from minimal to life-threatening. Health care providers must be familiar with these important new classes of drugs. This paper discusses the background, pharmacology, clinical effects, detection, and management of synthetic cannabinoid, synthetic cathinone, methoxetamine, and piperazine exposures.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 379 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 1%
Poland 2 <1%
United Kingdom 1 <1%
Canada 1 <1%
Switzerland 1 <1%
Unknown 369 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 55 15%
Researcher 50 13%
Student > Master 50 13%
Other 37 10%
Student > Bachelor 34 9%
Other 95 25%
Unknown 58 15%
Readers by discipline Count As %
Medicine and Dentistry 99 26%
Chemistry 40 11%
Agricultural and Biological Sciences 34 9%
Pharmacology, Toxicology and Pharmaceutical Science 32 8%
Psychology 25 7%
Other 75 20%
Unknown 74 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 82. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2024.
All research outputs
#530,280
of 25,789,020 outputs
Outputs from Journal of Medical Toxicology
#23
of 732 outputs
Outputs of similar age
#2,867
of 254,049 outputs
Outputs of similar age from Journal of Medical Toxicology
#2
of 15 outputs
Altmetric has tracked 25,789,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 732 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,049 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.